Revising the hemodynamic criteria for pulmonary hypertension: A perspective from China.

Authors:
Xiong C; Yang B.

Journal:
J Transl Int Med

Publication Year: 2023

DOI:
10.2478/jtim-2022-0023

PMCID:
PMC10202014

PMID:
37223616

View on PubMed View on PMC View Publisher
Journal Information

Full Title: J Transl Int Med

Abbreviation: J Transl Int Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Medicine, General & Internal

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Adrenomedullin induces cisplatin chemoresistance in ovarian cancer through reprogramming of glucose…
Dou L; Lu E; Tian D and 3 more (2023) - Transparency Score: 3/6
A generalized deep learning model for heart failure diagnosis using dynamic and static ultrasound.
Liu Z; Huang Y; Li H and 10 more (2023) - Transparency Score: 3/6
A newly-synthesized compound CP-07 alleviates microglia-mediated neuroinflammation and ischemic bra…
Guo M; Cao Q; Xia S and 5 more (2023) - Transparency Score: 3/6
Animal models: An essential tool to dissect the heterogeneity of chronic obstructive pulmonary dise…
Jiang J; Xu S; Chen Z and 5 more (2023) - Transparency Score: 3/6
A pan-cancer analysis of the oncogenic role of Golgi transport 1B in human tumors.
Tian B; Pang Y; Gao Y and 8 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of Interest: None declared."

Evidence found in paper:

"Source of Funding"

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025